Last reviewed · How we verify

NCT04307641: SPARQ_ACI

Improving Person Centered Care for Abortion Clients in India

Completed NA Last updated 24 May 2023
What this trial tests

NA trial testing 2 Page Information Sheet in Reproductive Health in 283 participants. Completed in 1 July 2018.

Timeline
1 November 2016
Primary endpoint
1 July 2018
1 July 2018

Quick facts

Lead sponsorUniversity of California, San Francisco
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment283
Start date1 November 2016
Primary completion1 July 2018
Estimated completion1 July 2018

Drugs / interventions tested

Conditions studied

Sponsor

University of California, San Francisco

Who can join

Eligibility, any sex, with Reproductive Health. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to understand the effect of providing pharmacists in UP, India with additional information about medication abortion.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Differential treatment in the provision of medication abortion at pharmacies in Uttar Pradesh, India.
    Percher J, Saxena M, Srivastava A, Diamond-Smith N. · · 2021 · cited 3× · PMID 36277455 · DOI 10.1016/j.xagr.2021.100025

Verify or expand the search:

Other recruiting trials for Reproductive Health

Currently open trials in the same condition.

Other University of California, San Francisco trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04307641.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing